Insmed | INSM

Aktienkurs
120.00
Täglich Wechseln
-3.98 -3.21%
Monatlich
-8.16%
Jährlich
-17.10%
Q3 Prognose
126.64

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-22 FY2026Q3 AM -0.61 -1.75
2026-08-06 FY2026Q2 AM -0.06 -0.75 -1.70
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 63.92 -1.16 -1.78% 17.59% 2026-09-18
Cytokinetics 68.78 -1.14 -1.63% 41.35% 2026-09-18
DBV Technologies 12.35 -0.16 -1.28% 30.00% 2026-09-18
Gilead Sciences 149.98 -0.91 -0.60% 31.46% 2026-09-18
Heron Therapeutics 0.31 -0.01 -1.90% -74.80% 2026-09-18
Insmed 120.00 -3.98 -3.21% -17.10% 2026-09-18
Novartis 140.46 -0.50 -0.35% 14.30% 2026-09-18
Ultragenyx Pharmaceutical 14.51 0.01 0.07% -48.42% 2026-09-18
Regeneron Pharmaceuticals 784.91 -4.54 -0.58% 32.59% 2026-09-18
Sarepta Therapeutics 20.13 -0.54 -2.61% 15.49% 2026-09-18

Preis Tag Jahr Datum
USND 26523 104.25 0.39% 17.19% 2026-09-18
US2000 2860 -14.62 -0.51% 16.79% 2026-09-18